When Dr. Alois Alzheimer first identified the disease that would bear his name in 1906, he could only confirm his diagnosis ...

KNX-100 is under clinical development by Kinoxis Therapeutics and currently in Phase II for Unspecified Psychiatric Disorders.

Alzheimer’s disease to deep brain stimulation reversing paralysis.Heading into the New Year, medical experts are predicting ...

A new study by researchers at the University of Waterloo demonstrates that antipsychotic medications ... used off-label as ...

“Antipsychotics are commonly used off-label as first-line agents for pharmacological treatment of behavioral and psychological symptoms of dementia (BPSD) in long-term care (LTC) facilities ...

While overall, combinations of cardiovascular drugs decreased dementia risk, only antihypertensives were able to do so alone with antiplatelets even increasing risk. Long-term combinatorial use of ...

The report noted that while all the women who testified said the sexual encounters with Gaetz were consensual, one woman told the committee the use of drugs at the parties and events they attended ...

London’s Drumsheds is at risk of losing its licence after reports of two drug-related deaths and a non-fatal stabbing on ... it was also connected to drug use. New DRUMSHEDS venue.

G2D2 will make full use of functional genetic analysis of dementia, and will engage in immuno-dementia drug discovery research ... developing and marketing AD treatments, Eisai has spent more ...

Current AHA guidelines call for healthy Americans to bring LDL below 100 milligrams per deciliter (mg/dL) of blood, while ...

In this episode of Drug Digest, industry experts discuss their experiences in dealing with the challenges of developing and manufacturing next-generation biotherapeutics as well as triumphs that move ...

His international drugs empire survived for 14 months, and in that time, Maximilian managed to use his website shinyflakes.com to change the drug trade in unthinkable ways. The documentary captures ...